http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1408989-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d115b7e3e01fc65e86ede7021d59736f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-732
filingDate 2002-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d155d1c257779f2591961cdfac50de27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ea3f0d17720dee2052c3e189b31a22
publicationDate 2004-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1408989-A2
titleOfInvention Method and material for treating immune diseases
abstract An immune response in an organism is controlled by administering to said organism a therapeutically effective amount of a compound which binds to a galectin. In specific instances the compound is selected to bind to galectin-1 or galectin-3. Some therapeutic materials comprise natural or synthetic polymers having galactose or arabinose terminated side chains pendent therefrom. A group of preferred therapeutic compounds comprise modified pectins or other materials having a substantially demethoxylated rhamnogalacturan backbone having rhamnose residues interrupting the backbone. One therapeutic material includes a first functional portion which binds to the carbohydrate binding portion of a galectin, and a second functional portion which is operable denature the galectin protein.
priorityDate 2001-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3956
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100025748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413228
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID786492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 44.